Identification of an Immune Classification and Prognostic Genes for Lung Adenocarcinoma Based on Immune Cell Signatures

OBJECTIVE: Current advances in immunotherapy requires accurate tumor sub-classification due to the heterogeneity of lung adenocarcinoma (LUAD). This study aimed to develop a LUAD sub-classification system based on immune cell signatures and identified prognostic gene markers. METHODS: Signatures rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Lili, Long, Fei, Wang, Ting, Dai, Ling, Chen, Huajian, Yang, Yujun, Xie, Guoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005848/
https://www.ncbi.nlm.nih.gov/pubmed/35433762
http://dx.doi.org/10.3389/fmed.2022.855387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005848/
https://www.ncbi.nlm.nih.gov/pubmed/35433762
http://dx.doi.org/10.3389/fmed.2022.855387

Ejemplares similares